Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Historical Holders from Q1 2020 to Q1 2025

Symbol
PASG on Nasdaq
CUSIP
702712100
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
61.7M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
37.6M
Holdings value
$21.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
44
Number of buys
17
Number of sells
-19
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 15% $5.25M 9.26M Lynx1 Capital Management LP Dec 31, 2024
ORBIMED ADVISORS LLC 12% $4.2M 7.4M ORBIMED ADVISORS LLC Dec 20, 2024
Erste Asset Management GmbH 4.42% -19.6% $1.39M -$192K 2.46M -17.1% Erste Asset Management GmbH Mar 31, 2024

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 50 $19.00 $0.38 1
2024 Q4 37.6M $21.6M -$666K $0.57 44
2024 Q3 38.7M $27.1M -$1.52M $0.70 43
2024 Q2 40.3M $32M -$251K $0.79 41
2024 Q1 40.3M $54.4M +$10.3M $1.35 48
2023 Q4 29.8M $30.1M +$22.4M $1.01 47
2023 Q3 100 $1K -$140K $10.00 1
2023 Q2 31.2M $29.4M -$2.63M $0.94 51
2023 Q1 34M $32.5M -$2.41M $0.96 53
2022 Q4 35.8M $49.4M -$1.87M $1.38 62
2022 Q3 37.7M $47.1M -$3.93M $1.25 60
2022 Q2 39.9M $94.2M -$2.84M $2.36 71
2022 Q1 41.6M $129M -$494K $3.10 95
2021 Q4 41M $261M -$25.1M $6.35 90
2021 Q3 42.1M $419M -$30M $9.96 99
2021 Q2 39M $516M -$7.52M $13.24 98
2021 Q1 45M $786M +$224M $17.48 86
2020 Q4 32M $818M +$42.1M $25.57 70
2020 Q3 30.8M $403M -$23.8M $13.11 66
2020 Q2 26.8M $732M +$35.9M $27.33 65
2020 Q1 29.2M $458M +$457M $15.75 45